Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
235 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Show all (1)
  • (-) Closed (1)

Medical Condition

  • Show all (644)
  • Autoimmune Disorders (1)
  • Blood Disorders (4)
  • Cancer (553)
  • COVID-19 (Coronavirus) (1)
  • Diabetes (1)
  • Ear, Nose and Throat (1)
    • (-) Hearing Loss (1)
  • Endocrine & Metabolic Disease (1)
  • Gastrointestinal and Digestive Diseases (2)
  • Healthy Volunteers (6)
  • Liver Disease (1)
  • Neurological Disorders (22)
  • Obstetrics & Gynecology (6)
  • Pediatrics (39)
  • Psychiatric Disorders (1)
  • Surgery (1)
  • Transplant (3)
  • Urology (1)
Displaying 1 - 1 of 1

A study to Assess Safety and Effectiveness of Study Drug OTO-104 in Patients at Risk of Hearing Loss From Cisplatin Chemotherapy

Condition: Ear, Nose and Throat / Hearing Loss
Investigator: Alice Lee, MD
Status: Closed
Cisplatin is a chemotherapy medicine that is used to treat a variety of cancers. At high total (cumulative) doses it can be associated with progressive and irreversible hearing loss. The purpose of this study is see if injections of OTO-104 can protect against hearing loss associated with cisplatin therapy in the treatment of…
Read More
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science